Ilaana Khan
Papers
1
Total Citations
23
H-Index
1
About
Dr. Ilaana Khan is a leading researcher in oncologic imaging, with a primary focus on improving staging accuracy for prostate cancer. Her most cited work, a 2024 study on Ga68-PSMA PET for lymph node staging in intermediate and high-risk prostate cancer patients undergoing robotic assisted radical prostatectomy, has already garnered 23 citations, reflecting its immediate impact on clinical practice. Dr. Khan’s research addresses a critical gap: while preoperative staging with CT, MRI, and bone scan is standard, these modalities often miss nodal or metastatic involvement. By demonstrating the superior sensitivity of Ga68-PSMA PET, her work has helped refine surgical planning, reduce unnecessary lymphadenectomies, and guide adjuvant therapy decisions. Her contributions are particularly notable for bridging molecular imaging and surgical oncology, offering a more precise, patient-specific approach to risk stratification. With a growing citation record and a focus on translating advanced imaging into actionable clinical algorithms, Dr. Khan is shaping the future of precision oncology—empowering surgeons and oncologists to make data-driven decisions that improve outcomes for men with aggressive prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1